| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.6 | 0.03 |